García MN, Cortés MO, Campos R, Ponce HJL, Careaga RG, Manterola C

Language: Spanish
References: 12
Page: 285-291
PDF size: 255.14 Kb.

ABSTRACT

Introduction: Patients with chronic kidney disease are at high risk of developing cardiomyopathy, atherosclerosis and arteriosclerosis. Atherosclerosis is the main cause of ischemic heart disease in CKD patients in substitute therapy such as dialysis (hemodialysis or peritoneal dialysis) and transplantation. In the case of dialysis, cardiovascular diseases increase the risk of arrhythmias and sudden cardiac death. Objectives: To provide a number of perioperative considerations to be taken into account during hemodynamic management of the chronic kidney disease patient by the multidisciplinary team involved in patient care with chronic kidney disease. Clinical case: We present a 52-year-old male patient with the following cardiovascular risk factors: age, sedentary lifestyle, hypertension, DMT2, CKD 5D KDIGO stage, congestive heart failure, New York Heart Association (NYHA) 2 and history of percutaneous coronary intervention (PCI) due to acute coronary syndrome, 5 years ago, in renal transplant protocol. The patient was successfully subjected to emergency PCI and during the endovascular procedure, a medicated balloon was placed. A In.Pact falcon™ DCB 3 x 20 mm intra stent to the prior DA and direct resolute onyx ™ DES 3.0 x 38 mm stent to the proximal segment of the circumflex artery. Conclusions: In this clinical case, coronary intervention was carried out successfully. The patient’s evolution was favorable due to follow-up by multidisciplinary team made up of nephrologists, hemodynamic specialist, cardiologists, intensive care doctors and anesthesiologists who participated in the Infarction Code group.

REFERENCES

1. México. Centro Nacional de Trasplantes. Datosabiertos [Internet]. Disponible en: (consulta: 15/02/2021).

2. Cozzolino M, Mangano M, Stucchi A, Ciceri P, ConteF, Galassi A. Cardiovascular disease in dialysis patients.Nephrol Dial Transplant. 2018;33(suppl. 3):iii28-iii34.doi: 10.1093/ndt/gfy174.

3. Gagnier JJ, Kienle G, Altman DG, Moher D, SoxH, Riley D; CARE Group. The CARE guidelines:consensus-based clinical case report guidelinedevelopment. J Clin Epidemiol. 2014;67(1):46-51. doi:10.1016/j.jclinepi.2013.08.003.

4. Institute for Health Metrics and Evaluation. GlobalBurden of Disease (GBD) Compare Data, Viz Hub[Internet]. Disponible en: (consulta: 15/02/2021).

5. Davenport MS, Perazella MA, Yee J, Dillman JR, FineD, McDonald RJ, et al. Use of Intravenous IodinatedContrast Media in Patients with Kidney Disease:Consensus Statements from the American Collegeof Radiology and the National Kidney Foundation.Radiology. 2020;294(3):660-8. doi: 10.1148/radiol.2019192094.

6. Guidance on gadolinium-based contrast agentadministration to adult patients [Internet]. RoyalCollege of Radiologists; april 2019. 22 p. Disponible en: (consulta: 15/02/2021).

7. ACS NSQIP Surgical Risk Calculator [Internet].American College of Surgeons, dec. 15 2020. Disponibleen: (consulta: 15/02/2021).

8. Chesebro JH, Knatterud G, Roberts R, Borer J,Cohen LS, Dalen J, et al. Thrombolysis in MyocardialInfarction (TIMI) Trial, Phase I: A comparisonbetween intravenous tissue plasminogen activator andintravenous streptokinase. Clinical findings throughhospital discharge. Circulation. 1987;76(1):142-54.doi: 10.1161/01.cir.76.1.142.

9. Flores-Gama C, Merino M, Baranda F, CruzDN, Ronco C, Vázquez-Rangel A. The impact ofintegrating nephrologists into the postoperative cardiacintensive care unit: a cohort study. Cardiorenal Med.2013;3(1):79-88. doi: 10.1159/000350545.

10. García Méndez N, Carrillo Sierra A, Ortiz GalvánRC, Manterola C, Otzen T, Cuevas Domínguez A.Trasplante renal en bloque: a propósito de un caso. RevNefrol Dial Traspl. 2019; 39(1):50-4.

11. Baber U, Farkouh ME, Arbel Y, Muntner P, Dangas G,Mack MJ, et al. Comparative efficacy of coronary arterybypass surgery vs. percutaneous coronary interventionin patients with diabetes and multivessel coronary arterydisease with or without chronic kidney disease. Eur HeartJ. 2016;37(46):3440-7. doi: 10.1093/eurheartj/ehw378.

12. Giustino G, Mehran R, Serruys PW, Sabik JF3rd, Milojevic M, Simonton CA, et al. Left mainrevascularization with PCI or CABG in patients withchronic kidney disease: EXCEL trial. J Am Coll Cardiol.2018;72(7):754-65. doi: 10.1016/j.jacc.2018.05.057.